Jiangsu Wuzhong Receives $1.8 Million to Develop Cancer Drug

Jiangsu Wuzhong Industrial announced it has been awarded a subsidy of 12 million RMB ($1.8 million) to develop a cancer drug. Wuzhong owns the IP for the drug, whose mechanism of action was not disclosed. More details.... Stock Symbol: (SHA: 600200)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.